MedTrace Logo

Ultrasound Measure of Gastric Volume in Diabetic and Non Diabetic Patients Before General Anesthesia

NCT03036774 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 245

Last updated 2020-01-14

No results posted yet for this study

Summary

The main objective is to compare the frequency of a " full stomach " in diabetic patients compared with a control population, all the patients having followed the instructions of preoperative fast.

Conditions

Interventions

PROCEDURE

Ultrasonic measurement of antral area

Antral area is measured by ultrasound using a curvilinear abdominal probe of 2-5 MHz and a Logiq E (General Electrics) type echograph or equivalent. Ultrasound is done before the induction of general anesthesia. Three consecutive measurements of the anteroposterior (AP) and cranio-caudal (CC) diameters are performed. Antral area (CSA expressed in mm²) is show by the following formula: CSA = AP × CC × π / 4. Antral area will correspond to the average of the three measures.

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Julien Rousset, MD · Hôpital Tenon

  • Marc Fischler, MD-PhD · Hôpital Foch

  • Francis Bonnet, MD-PhD · HopitalTenon

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-14
Primary Completion
2019-02-06
Completion
2019-02-06

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03036774 on ClinicalTrials.gov